Code | 6828C | ||||||||||
MA number | 16/0027/18-S | ||||||||||
Product Form: | tbl 90x100 mg (blis.PVC/PVDC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Medreg s.r.o., Czechia | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/PVDC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10a well-established use application |
MA issued: | 25.01.2018 |
Dokument: | VHS_súhrn_Kyselina acetylsalicylová Xantis.pdf |
Dokument: | VHS_Kyselina acetylsalicylová Xantis.pdf |
SPC: | SPC_Carlagirin_02.2023.pdf |
PIL: | PIL_Carlagirin_02.2023.pdf |
Safety feature | Yes |
Data update: | 06.03.2023 |